Adverse events90

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 90

Type	Event	Organ system	Group	Affected	At risk
other	Blood creatinine increased	Investigations	Azilsartan Medoxomil 20-40mg Plus Chlorthalidone 12.5-25 mg QD	36	372
other	Blood creatinine increased	Investigations	Azilsartan Medoxomil 40-80mg Plus Chlorthalidone 12.5-25 mg QD	44	357
other	Blood creatinine increased	Investigations	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	25	356
other	Dizziness	Nervous system disorders	Azilsartan Medoxomil 20-40mg Plus Chlorthalidone 12.5-25 mg QD	25	372
other	Dizziness	Nervous system disorders	Azilsartan Medoxomil 40-80mg Plus Chlorthalidone 12.5-25 mg QD	24	357
other	Dizziness	Nervous system disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	20	356
other	Headache	Nervous system disorders	Azilsartan Medoxomil 20-40mg Plus Chlorthalidone 12.5-25 mg QD	14	372
other	Headache	Nervous system disorders	Azilsartan Medoxomil 40-80mg Plus Chlorthalidone 12.5-25 mg QD	14	357
other	Headache	Nervous system disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	18	356
serious	Cardiac arrest	Cardiac disorders	Azilsartan Medoxomil 20-40mg Plus Chlorthalidone 12.5-25 mg QD	0	372
serious	Cardiac arrest	Cardiac disorders	Azilsartan Medoxomil 40-80mg Plus Chlorthalidone 12.5-25 mg QD	1	357
serious	Cardiac arrest	Cardiac disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	1	356
serious	Coronary artery disease	Cardiac disorders	Azilsartan Medoxomil 20-40mg Plus Chlorthalidone 12.5-25 mg QD	0	372
serious	Coronary artery disease	Cardiac disorders	Azilsartan Medoxomil 40-80mg Plus Chlorthalidone 12.5-25 mg QD	0	357
serious	Coronary artery disease	Cardiac disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	1	356
serious	Diastolic dysfunction	Cardiac disorders	Azilsartan Medoxomil 20-40mg Plus Chlorthalidone 12.5-25 mg QD	0	372
serious	Diastolic dysfunction	Cardiac disorders	Azilsartan Medoxomil 40-80mg Plus Chlorthalidone 12.5-25 mg QD	1	357
serious	Diastolic dysfunction	Cardiac disorders	Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD	0	356
serious	Diarrhoea	Gastrointestinal disorders	Azilsartan Medoxomil 20-40mg Plus Chlorthalidone 12.5-25 mg QD	1	372
serious	Diarrhoea	Gastrointestinal disorders	Azilsartan Medoxomil 40-80mg Plus Chlorthalidone 12.5-25 mg QD	0	357

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00846365/events

API reference For AI assistants

Adverse events90

Sources 3

Read this list from software.